Sign in
  Edit search
Design of fully synthetic, self-adjuvanting vaccine incorpor…
Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand.
Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand.
Article, Chapter
Authors: Abu-Baker M AB Abdel-Aal
Publication: Journal of Medicinal Chemistry, Volume:55, Issue:15, Page(s):6968-6974
Published: American Chemical Society, 2012-8-09
ISSN: 0022-2623
DOI: 10.1021/jm300822g
  Full text availability for this item
View Full Text Source:Journal of Medicinal Chemistry,Journal of Medicinal Chemistry,American Chemical Society Journals (Front Files) Opens in new Window
Journal:  Journal of Medicinal Chemistry Source:American Chemical Society Journals (Front Files) Opens in new Window
Collection:  American Chemical Society Journals (Front Files) Opens in new Window
Coverage:
  • 1996~present; volume:39~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item